| DC Field | Value | Language |
|---|
| dc.contributor.author | Khavinson, V. Kh. | - |
| dc.contributor.author | Linkova, N. S. | - |
| dc.contributor.author | Umnov, R. S. | - |
| dc.date.accessioned | 2023-03-02T13:42:01Z | - |
| dc.date.available | 2023-03-02T13:42:01Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.citation | Khavinson, V.Kh. Peptide KED: molecular-genetic aspects of neurogenesis regulation in Alzheimer’s disease / Khavinson V.Kh., N.S. Linkova, R.S. Umnov // Bulletin of Experimental Biology and Medicine. - 2021. - Vol.171, №2.-P. 190-193. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/51987 | - |
| dc.description.abstract | Neuroprotective peptides are promising candidate molecules for the treatment of Alzheimer’s disease (AD). Oral application of KED (Lys-Glu-Asp) improved memory and attention in elderly individuals with functional CNS disorders. Peptide KED also restores synaptic plasticity in in vitro model of AD. This review is focused on the analysis of the influence of KED peptide on the expression of genes and synthesis of proteins regulating apoptosis, aging, neurogenesis, and involved in AD pathogenesis | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | peptide KED | ru |
| dc.subject | gene expression | ru |
| dc.subject | neuroprotection | ru |
| dc.subject | Alzheimer’s disease | ru |
| dc.title | Peptide KED: molecular-genetic aspects of neurogenesis regulation in Alzheimer’s disease | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
